BlackRock, Inc. 13D and 13G filings for Kinnate Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-06 09:29 am Sale | 2023-03-31 | 13G | Kinnate Biopharma Inc. KNTE | BlackRock Inc. BLK | 2,277,109 4.900% | -58,709 (-2.51%) | Filing |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Kinnate Biopharma Inc. KNTE | BlackRock Inc. BLK | 2,335,818 5.300% | 2,335,818 (New Position) | Filing |